Stockreport

CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

CG Oncology, Inc. - Common stock  (CGON) 
PDF IRVINE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercia [Read more]